Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02785159 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
A Phase 2 study, sponsored by Bausch Health Americas.
- Completed
- Registry status
- Phase 2
- Development phase
- 152
- Enrollment target
NCT02785159 is a Phase 2 study that has completed, run by Bausch Health Americas. The registered enrollment target is 152 participants.
The verdict
NCT02785159, a Phase 2 study, has completed, sponsored by Bausch Health Americas.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 152 participants
- Enrollment target
Study Summary
Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
Interventions
- DRUG IDP-118 Lotion
- DRUG Tazorac Cream
- DRUG IDP-118 Vehicle Lotion
- DRUG IDP-118 Vehicle Cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2016-02 |
| Est. Completion | 2016-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02785159
The ClinicalTrials.gov registry entry for NCT02785159 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch Health Americas, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which IDP-118 Lotion is the first listed.
NCT02785159 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02785159 about?
NCT02785159 is a clinical study titled "Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis". Safety and Efficacy of IDP-118 Lotion in the Treatment of Plaque Psoriasis
What is the current status of trial NCT02785159?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 152 participants. The study started on 2016-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02785159?
The interventions under investigation include: IDP-118 Lotion (DRUG), Tazorac Cream (DRUG), IDP-118 Vehicle Lotion (DRUG), IDP-118 Vehicle Cream (DRUG).
Who is sponsoring clinical trial NCT02785159?
This trial is sponsored by Bausch Health Americas, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.